Ads
related to: symptomatic obstructive hypertrophic cardiomyopathy (hcm)- What Is Obstructive HCM?
Get More Information On
A Type Of HOCM And What Causes It.
- HCM Treatment Option
How HCM Treatment Works,
Find Out More On The Patient Site.
- Clinical Trial Results
Review Clinical Trial Info For
An FDA-Approved Treatment Option.
- Enrolling In Treatment
Get Dosing And Treatment
Schedule Information.
- What Is Obstructive HCM?
Search results
Cytokinetics (CYTK) Up 83% as Cardiomyopathy Drug Meets Goals
Zacks via Yahoo Finance· 5 months agoCytokinetics (CYTK) reports positive results from its pivotal late-stage study of aficamten in...
Bristol Myers (BMY) Heart Drug Camzyos Wins EC Approval
Zacks via Yahoo Finance· 11 months agoBristol Myers (BMY) receives EC approval for Camzyos for treating symptomatic (New York Heart...
Cytokinetics (CYTK) Rises on Reports of Buyout by Novartis
Zacks via Yahoo Finance· 5 months agoShares of Cytokinetics, Incorporated CYTK increased 15.29% after reports of a plausible acquisition...
LianBio Touts Positive Data From Bristol Myers-Partnered Heart Drug In Chinese Patients
Benzinga via Yahoo Finance· 1 year agoLianBio (NASDAQ: LIAN) announced topline results from the Phase 3 EXPLORER-CN trial investigating...
Biotech Stock Roundup: SRPT's DMD Therapy Approval, ICPT's Setback & More Updates
Zacks via Yahoo Finance· 11 months agoIt was a busy week for the biotech sector. Key regulatory and pipeline updates from Sarepta...
Cytokinetics Has Clawed Back 105% Over Seven Days. Now It Could Score A Buyout.
Investor's Business Daily· 5 months agoNovartis is closing in on a takeover of Cytokinetics, the Wall Street Journal reported Monday. CYTK...
Bristol Myers (BMY) Up 20.4% YTD: Will the Momentum Continue?
Zacks via Yahoo Finance· 2 years agoShares of Bristol Myers BMY have jumped 20.4% in the year so far against the industry’s decline of...
Cytokinetics Stock Jumps To Higher RS Level; Shoots Up On Heart Drug Study
Investor's Business Daily· 5 months agoOn Thursday, Cytokinetics cleared a key performance benchmark, with its Relative Strength (RS)...
Biotech Stock Roundup: FGEN Down on Study Failure, BMY Drug's Label Expansion & More
Zacks via Yahoo Finance· 9 months agoIt was a busy week for the biotech sector, with quite a few important regulatory and pipeline...
Will Bristol Myers (BMY) Gain From New Drugs' Label Expansion?
Zacks via Yahoo Finance· 1 year agoBristol-Myers Squibb BMY has recently been enjoying a string of positive regulatory updates. The...
Ads
related to: symptomatic obstructive hypertrophic cardiomyopathy (hcm)
